Drug-eluting stents.
Copyright policy )Drug-eluting stents.
Drug-eluting stents are designed to reduce the risk of major adverse cardiac events after percutaneous coronary intervention by inhibiting cellular proliferation and reducing restenosis of the coronary artery. In high-risk lesions, drug-eluting stents may limit restenosis and the need for repeat revascularization. In optimal lesions, they may eliminate restenosis completely. Drug-eluting stents have made percutaneous intervention a safe and definitive treatment for coronary artery disease.
Coronary Restenosis, Sirolimus, Clinical Trials as Topic, Paclitaxel, Humans, Coronary Disease, Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Diabetic Angiopathies, Immunosuppressive Agents
Coronary Restenosis, Sirolimus, Clinical Trials as Topic, Paclitaxel, Humans, Coronary Disease, Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Diabetic Angiopathies, Immunosuppressive Agents
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!